Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.

Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.

The reported rates of HER2 positivity in cervical cancer (CC) range from 0% to 87%. The importance of HER2 as an actionable target in CC would depend on HER2 positivity prevalence. Our aim was to provide precise estimates of HER2 overexpression and amplification in CC, globally and by relevant subgr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Boris Itkin, Agustin Garcia, Samanta Straminsky, Eduardo Daniel Adelchanow, Matias Pereyra, Gabriela Acosta Haab, Ariel Bardach
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/ab8ebf92343e4ebdb6a4668c08a9319c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares